Scarica l'app Stockscreener
114.87
0.65%
-0.75
Dopo l'orario di chiusura:
114.91
0.04
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$115.62
Aprire:
$116.23
Volume 24 ore:
2.08M
Relative Volume:
0.96
Capitalizzazione di mercato:
$32.46B
Reddito:
$7.07B
Utile/perdita netta:
$1.29B
Rapporto P/E:
25.33
EPS:
4.5355
Flusso di cassa netto:
$993.00M
1 W Prestazione:
-5.91%
1M Prestazione:
+4.20%
6M Prestazione:
-21.24%
1 anno Prestazione:
+7.49%
Intervallo 1D:
$114.10
$116.64
Intervallo di 1 settimana:
$111.98
$123.30
Portata 52W:
$104.10
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
114.87 | 32.67B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
470.22 | 173.93B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
178.98 | 127.84B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
568.30 | 45.67B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
300.73 | 29.43B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27 - 01net
Vanguard Portfolio Management reports 14.39M shares in Agilent (NYSE: A) - Stock Titan
Vanguard Group Inc. Raises Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Adjusts Valuation Amidst Declining Profits and Strong Financial Metrics - Markets Mojo
Agilent Technologies, Inc. $A Stock Holdings Decreased by Pictet Asset Management Holding SA - MarketBeat
At US$116, Is It Time To Put Agilent Technologies, Inc. (NYSE:A) On Your Watch List? - Yahoo Finance
Teacher Retirement System of Texas Sells 66,755 Shares of Agilent Technologies, Inc. $A - MarketBeat
Here's what to expect from Agilent Technologies’ next earnings report - MSN
Agilent Q1 earnings miss estimates, revenues up Y/Y, shares fall - MSN
Agilent Technologies declares $0.255 dividend - MSN
Agilent opens new biopharma centre in Hyd - MSN
Agilent Technologies Inc. stock (US00846U1016): Why its life sciences leadership matters more now fo - AD HOC NEWS
Agilent Technologies Inc. stock (US00846U1016): Why Google Discover changes matter more now - AD HOC NEWS
Agilent Technologies Q4 2025 Earnings Preview - MSN
Is Agilent Technologies stock underperforming the S&P 500? - MSN
Agilent Technologies, Inc. $A is Impax Asset Management Group plc's 6th Largest Position - MarketBeat
Agilent doubling headcount in India - The Economic Times
Here's What to Expect From Agilent Technologies’ Next Earnings Report - Yahoo Finance
Agilent Technologies Inc (NYSE:A): A Quality Investing Candidate with Strong Profitability and Cash Flow - ChartMill
Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues? - simplywall.st
Gotham Absolute Return Fund's Agilent Technologies Inc(A) Holding History - GuruFocus
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 54,276 Shares of Agilent Technologies, Inc. $A - MarketBeat
Boston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat
Is Agilent Technologies a Better Buy Than Danaher? - Trefis
Agilent appoints Rodney Gonsalves as interim CFO following McMahon’s departure - MSN
Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation - The AI Journal
TRADE NEWS: Agilent Technologies Introduces HaloPlex Next-Generation Sequencing Panels Targeting Can - Yahoo
Agilent’s Expanding Role in Advanced Therapeutics - Contract Pharma
Agilent Technologies (A) Launches Key Cancer Diagnostic Tool - GuruFocus
Agilent Technologies, Inc. $A Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Agilent Technologies Inc. stock (US00846U1016): Is life sciences strength enough to drive steady gai - AD HOC NEWS
Axion Biosystems and Agilent Technologies Res - Moomoo
Axion Biosystems And Agilent Technologies Resolve Litigation - TradingView
Agilent bets on pathology innovation with Biocare acquisition - MSN
Axion BioSystems and Agilent Technologies Resolve Litigation - Business Wire
Mirae Asset Global Investments Co. Ltd. Grows Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc stock (US00846U1016): Why Google Discover changes matter more now - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 31.85% Potential Upside for Investors - DirectorsTalk Interviews
Chromatograph (Labor): Precision Tools Drive Agilent's Lab Market Edge - AD HOC NEWS
Agilent Cancer Research Push Spurs Collaboration Focus And Investor Reassessment - Yahoo Finance
Chromatograph (Labor): Advances in Tech Boost Agilent's Lab Market Edge - AD HOC NEWS
11,390 Shares in Agilent Technologies, Inc. $A Acquired by Lecap Asset Management Ltd. - MarketBeat
KBC Group NV Has $11.17 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Stock Performance & Valuation Analysis 2026 | Business ReviewNews and Statistics - IndexBox
Is Agilent’s Oncology Push and Oxford Nanopore Tie-Up Quietly Reframing Its Investment Narrative (A)? - Sahm
Agilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocus
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):